{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Galecto, Inc.
Is Galecto, Inc. technically bullish or bearish?
As of May 12, 2025, the trend is mildly bearish, influenced by daily moving averages and mixed signals from weekly and monthly indicators like MACD, RSI, and KST.
What does Galecto, Inc. do?
Galecto, Inc. is a clinical-stage biotechnology company focused on developing therapeutics for fibrosis and related diseases. As of March 2025, it has a market cap of $4.26 million and reported a net profit loss of $3 million.
How big is Galecto, Inc.?
As of Jun 18, Galecto, Inc. has a market capitalization of 4.26 million, categorizing it as a Micro Cap company, with net sales of 0.00 million and a net profit of -18.49 million over the latest four quarters. The company reported shareholder's funds of 14.47 million and total assets of 17.13 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
